Polar pollutants entry into the water cycle by municipal wastewater: a European perspective

The effluents of eight municipal wastewater treatment plants (WWTP) in Western Europe were analyzed by liquid-chromatography-mass spectrometry for the occurrence of 36 polar pollutants, comprising household and industrial chemicals, pharmaceuticals, and personal care products. In a long-term study of the effluents of three WWTP over 10 months, sulfophenyl carboxylates and ethylene diamino tetraacetate (EDTA) were detected above 10 microg/L on average, while benzotriazoles, benzothiazole-2-sulfonate, diclofenac, and carbamazepine showed mean concentrations of 1-10 microg/L, followed by some flame retardants, naphthalene disulfonates, and personal care products in the range of 0.1-1 microg/L. Half of the determined compounds were not significantly removed in tertiary wastewater treatment. By dividing the effluent concentration of a compound by its relative removal in WWTP a water cycle spreading index (WCSI) was calculated for each compound. We propose that this index provides a measure for the potential of a polar compound to spread along a partially closed water cycle after discharge with municipal wastewater and to occur in raw waters used for drinking water production. Polar pollutants in surface water samples of different catchments showed increasing concentration for compounds with increasing WCSI.     

Removal of organics and degradation products from industrial wastewater by a membrane bioreactor integrated with ozone or UV/H₂O₂ treatment

The treatment of a pharmaceutical wastewater resulting from the production of an antibacterial drug (nalidixic acid) was investigated employing a membrane bioreactor (MBR) integrated with either ozonation or UV/H(2)O(2) process. This was achieved by placing chemical oxidation in the recirculation stream of the MBR. A conventional configuration with chemical oxidation as polishing for the MBR effluent was also tested as a reference. The synergistic effect of MBR when integrated with chemical oxidation was assessed by monitoring (i) the main wastewater characteristics, (ii) the concentration of nalidixic acid, (iii) the 48 organics identified in the raw wastewater and (iv) the 55 degradation products identified during wastewater treatment. Results showed that MBR integration with ozonation or UV/H(2)O(2) did not cause relevant drawbacks to both biological and filtration processes, with COD removal rates in the range 85-95%. Nalidixic acid passed undegraded through the MBR and was completely removed in the chemical oxidation step. Although the polishing configuration appeared to give better performances than the integrated system in removing 15 out of 48 secondary organics while similar removals were obtained for 19 other compounds. The benefit of the integrated system was however evident for the removal of the degradation products. Indeed, the integrated system allowed higher removals for 34 out of 55 degradation products while for only 4 compounds the polishing configuration gave better performance. Overall, results showed the effectiveness of the integrated treatment with both ozone and UV/H(2)O(2).     

Occurrence and fate of carbamazepine,clofibric acid,diclofenac, ibuprofen,ketoprofen, and naproxen in surface waters

Although various single-concentration measurements of pharmaceuticals are available in the literature, detailed information on the variation over time of the concentration and the load in wastewater effluents and rivers and on the fate of these compounds in the aquatic environment are lacking. We measured the concentrations of six pharmaceuticals, carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen, in the effluents of three wastewater treatment plants (WWTPs), in two rivers and in the water column of Lake Greifensee (Switzerland) over a time period of three months. In WWTP effluents, the concentrations reached 0.95 microg/L for carbamazepine, 0.06 microg/L for clofibric acid, 0.99 microg/L for diclofenac, 1.3 microg/L for ibuprofen, 0.18 microg/L for ketoprofen, and 2.6 microg/L for naproxen. The relative importance in terms of loads was carbamazepine, followed by diclofenac, naproxen, ibuprofen, clofibric acid, and ketoprofen. An overall removal rate of all these pharmaceuticals was estimated in surface waters, under real-world conditions (in a lake), using field measurements and modeling. Carbamazepine and clofibric acid were fairly persistent. Phototransformation was identified as the main elimination process of diclofenac in the lake water during the study period. With a relatively high sorption coefficient to particles, ibuprofen might be eliminated by sedimentation. For ketoprofen and naproxen, biodegradation and phototransformation might be elimination processes. For the first time, quantitative data regarding removal rates were determined in surface waters under real-world conditions. All these findings are important data for a risk assessment of these compounds in surface waters.     

Recent advances in environmental risk assessment of transformation products

When micropollutants degrade in the environment, they may form persistent and toxic transformation products, which should be accounted for in the environmental risk assessment of the parent compounds. Transformation products have become a topic of interest not only with regard to their formation in the environment, but also during advanced water treatment processes, where disinfection byproducts can form from benign precursors. In addition, environmental risk assessment of human and veterinary pharmaceuticals requires inclusion of human metabolites as most pharmaceuticals are not excreted into wastewater in their original form, but are extensively metabolized. All three areas have developed their independent approaches to assess the risk associated with transformation product formation including hazard identification, exposure assessment, hazard assessment including dose-response characterization, and risk characterization. This review provides an overview and defines a link among those areas, emphasizing commonalities and encouraging a common approach. We distinguish among approaches to assess transformation products of individual pollutants that are undergoing a particular transformation process, e.g., biotransformation or (photo)oxidation, and approaches with the goal of prioritizing transformation products in terms of their contribution to environmental risk. We classify existing approaches for transformation product assessment in degradation studies as exposure- or effect-driven. In the exposure-driven approach, transformation products are identified and quantified by chemical analysis followed by effect assessment. In the effect-driven approach, a reaction mixture undergoes toxicity testing. If the decrease in toxicity parallels the decrease of parent compound concentration, the transformation products are considered to be irrelevant, and only when toxicity increases or the decrease is not proportional to the parent compound concentration are the TPs identified. For prioritization of transformation products in terms of their contribution to overall environmental risk, we integrate existing research into a coherent model-based, risk-driven framework. In the proposed framework, read-across from data of the parent compound to the transformation products is emphasized, but limitations to this approach are also discussed. Most prominently, we demonstrate how effect data for parent compounds can be used in combination with analysis of toxicophore structures and bioconcentration potential to facilitate transformation product effect assessment.     

Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment

In Mediterranean regions where the population is rapidly growing, the risk of water resource contamination by wastewater is likely to increase. This is the case of the Hérault watershed (south of France), where the presence of treated wastewater in surface and ground waters has been shown in a previous study. To assess the consequence of these wastewater contaminations as regards pharmaceuticals and other organic compounds, 16 common pharmaceuticals (amitryptilin, acetylsalicylic acid, carbamazepine, clenbuterol, diazepam, diclofenac, doxepin, gemfibrozil, ibuprofen, imipramine, ketoprofen, naproxen, nordiazepam, paracetamol, salbutamol, and terbutalin) as well as wastewater related pollutants (caffeine, gadolinium anomaly, and boron) were analyzed in wells pumped for potable water supply and in two wastewater treatment plant (WWTP) effluents. In addition, a monitoring along the Lergue River (the main tributary of the Hérault River) was achieved to assess pharmaceutical behavior in surface waters. Pharmaceuticals and other wastewater-related contaminants are present in several reservoirs tapped for drinking water, confirming wastewater contamination; paracetamol, caffeine, and diclofenac are the most frequently detected. Paracetamol is present at rather high concentrations (up to 11 microg/L and 211 ng/L, respectively, in a wastewater effluent and in a drinking water sample). Though degradable in WWTP, caffeine is commonly encountered in surface waters and detected in highly polluted groundwater. On the contrary, acetylsalicylic acid concentrations are generally low despite a large consumption in France; this is related to its metabolism in humans and rapid degradation in the aquatic environment. The monitoring of pharmaceuticals along the Lergue River shows that dilution is sufficient to decrease pharmaceutical values.     

Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study

To reduce the release of pharmaceuticals and endocrine disruptors into the aquatic environment or to remove them from wastewater intended for direct or indirect reuse, the application of advanced wastewater treatment may be required. In the present study, municipal wastewater effluents were treated with ozone (O3) in a pilot-scale plant consisting of two bubble columns. The investigated effluents, which varied in suspended solids concentrations, comprised an effluent of conventional activated sludge treatment (CAS), the same effluent dosed with 15 mg of TSS L(-1) of activated sludge (CAS + SS), and the effluent of a membrane bioreactor pilot plant (MBR). Selected classes of pharmaceuticals were spiked in the wastewater at realistic levels ranging from 0.5 to 5 microg L(-1). Samples taken at the inlet and the outlet of the pilot plant were analyzed with liquid chromatography (LC)-electrospray tandem mass spectrometry (MS). Macrolide and sulfonamide antibiotics, estrogens, and the acidic pharmaceuticals diclofenac, naproxen, and indomethacin were oxidized by more than 90-99% for O3 doses > or = 2 mg L(-1) in all effluents. X-ray contrast media and a few acidic pharmaceuticals were only partly oxidized, but no significant differences were observed among the three effluents. These results show that many pharmaceuticals present in wastewater can be efficiently oxidized with O3 and that suspended solids have only a minor influence on the oxidation efficiency of nonsorbing micropollutants.     

Evaluation of perfluorooctane surfactants in a wastewater treatment system and in a commercial surface protection product

The origin and amount of perfluorooctane surfactants in wastewater treatment systems, and the transformation these compounds may undergo during treatment, were evaluated through measurement and experiment. Influent, effluent, and river water at the point of discharge for a 6-MGD wastewater treatment plant (WWTP) were screened for eight perfluorooctane surfactants. N-EtFOSAA was quantified in influent (5.1 +/- 0.8 ng/L), effluent (3.6 +/- 0.2 ng/ L), and river water samples (1.2 +/- 0.3 ng/L), while PFOS and PFOA were quantified in effluent (26 +/- 2.0 and 22 +/- 2.1 ng/L, respectively) and river water (23 +/- 1.5 and 8.7 +/- 0.8 ng/L, respectively). Signals for PFOS and PFOA were observed in influent samples, but exact quantitative determination could not be made due to low recoveries of these two compounds in field spike samples. Although the source of PFOS and PFOA observed in WWTP effluents is not clear, two hypotheses were examined: (1) the highly substituted perfluorooctane surfactants that constitute commercially available fabric protectors can be transformed to PFOS and PFOA during biological treatment in wastewater treatment systems, and (2) the end products themselves are directly introduced to WWTPs because they are present as residual in the commercial mixtures. Biotransformation experiments of 96 h were run to determine whether N-EtFOSE (a primary monomer used in 3M's polymer surface protection products) could be transformed to lesser-substituted perfluorooctane compounds in bioreactors amended with aerobic and anaerobic sludge from the sampled plant. At the end of the aerobic biotransformation experiment, N-EtFOSAA and PFOSulfinate were the only two metabolites formed and each accounted for 23 +/- 5.0% and 5.3 +/- 0.8% of the transformed parent on a molar basis, respectively. Transformation of N-EtFOSE was not observed under anaerobic conditions. A sample of a commercially available surface protection product from 1994 was analyzed and found to contain six of the targeted perfluorinated surfactants, including PFOS and PFOA. These findings suggest transformation of precursors within wastewater treatment is not an important source of these compounds compared to direct use and disposal of products containing the end products as residual amounts.     

An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals

In recent times, trace levels of pharmaceuticals detected in wastewater effluents and surface waters have raised the level of attention around the ultimate fate and the potential persistence of pharmaceuticals in the environment. We have seen the European Agency for the Evaluation of Medicines (EMEA) recently include more rigorous environmental fate testing in European Union (EU) Environmental Risk Assessment (ERA) guidance to assess the ultimate fate in water/sediment systems. Yet to date, there is little data available that covers the fate of pharmaceuticals in the water/sediment compartment, and little that assess whether current aerobic and anaerobic methods are appropriate for pharmaceuticals. In this study, the biodegradation profiles of 3 Pfizer products were investigated following the latest ERA guidance and its recommendation for OECD 308 water/sediment biodegradation testing. Experiments included 14C-labeled exemestane, azithromycin, and varenicline representing neutral and cationic pharmaceuticals with average K(oc) values of 3704, 49 400, and 10 483 respectively. Specific HPLC/radioactive monitoring (RAM) methods were used to profile water and sediment samples for biotransformation products. Binding to sediment, as "non-extractables", was considerable for all three pharmaceuticals, though most notable for the cationic pharmaceuticals varenicline and azithromycin ranging from 52% to 94% at study termination, respectively. In general, for all 3 pharmaceuticals studied, the anaerobic conditions demonstrated less biotransformation and mineralization than the aerobic; though their biotransformation profile (number of metabolites) and amount bound to sediment were similar. Based on these findings and our current understanding of anaerobic biodegradation, we would recommend a tiered approach to the OECD 308 water/ sediment test: with default testing just for aerobic conditions; and then if needed, anaerobic testing only for those compounds potentially amenable to typical anaerobic processes. We suggest that as a simulation test would be better suited in later tier testing under EU ERA guidance. Inherent biodegradation or die-away tests seem better suited to derive biodegradation rate constants for subsequent environmental modeling of water and sediment compartments.     

二氧化氯催化氧化法处理造纸中段废水

采用二氧化氯催化氧化法对某厂的造纸中段废水进行了处理,探讨了在催化氧化处理过程中CIO2用量、催化剂投加剂量、反应pH值、反应时间对中段废水催化氧化处理效果的影响。实验结果表明,在二氧化氯投加量为40mg／100mL,反应pH值为5,处理时间为90min,催化剂用量为2．5g／100mL且重复使用4次的条件下。可使中段废水主要污染物CODcr的去除率超过42％,有利于废水后续生化处理。     

Odorous compounds in municipal wastewater effluent and potable water reuse systems

The presence of effluent-derived compounds with low odor thresholds can compromise the aesthetics of drinking water. The potent odorants 2,4,6-trichloroanisole and geosmin dominated the profile of odorous compounds in wastewater effluent with concentrations up to 2 orders of magnitude above their threshold values. Additional odorous compounds (e.g., vanillin, methylnaphthalenes, 2-pyrrolidone) also were identified in wastewater effluent by gas chromatography coupled with mass-spectrometry and olfactometry detection. Full-scale advanced treatment plants equipped with reverse osmosis membranes decreased odorant concentrations considerably, but several compounds were still present at concentrations above their odor thresholds after treatment. Other advanced treatment processes, including ozonation followed by biological activated carbon and UV/H(2)O(2) also removed effluent-derived odorants. However, no single treatment technology alone was able to reduce all odorant concentrations below their odor threshold values. To avoid the presence of odorous compounds in drinking water derived from wastewater effluent, it is necessary to apply multiple barriers during advanced treatment or to dilute wastewater effluent with water from other sources.     

Photocatalytic degradation characteristics of different organic compounds at TiO2 nanoporous film electrodes with mixed anatase/ rutile phases

Nanoporous TiO2 film electrodes with a mixed anatase/ rutile phase were prepared by dip-coating TiO2 nanoparticle colloid onto Indium Tin Oxide (ITO) conducting glass substrates and a subsequent calcination process at 700 degrees C for 16 h. The photocatalytic oxidation of a wide range of organic compounds has been studied using the photoelectrochemical method under the conditions that the photohole capturing step controls the overall photocatalytic processes. The characteristics of the mixed anatase/ rutile phase TiO2 film electrodes were compared with pure anatase phase TiO2 film electrodes to identify the key differences between them. The results revealed that different organic compounds, despite their difference in chemical entities, can be stoichiometrically mineralized at the mixed-phase TiO2 electrode under diffusion-controlled conditions, which is in great contrast to the situation at the pure anatase phase TiO2 electrode. The exceptional ability of the mixed-phase TiO2 electrodes for mineralization of organic compounds and their remarkable resistance to the inhibition by aromatic compounds at higher concentration has been explained by the synergetic effect of the rutile and anatase phases. For this type of mixed phase electrodes, upon absorption of UV light, the electron-transfer pathway from anatase phase to rutile phase facilitates the separation of photoelectron and photohole, extending the lifetime of the photoelectron and photohole.     

Fate of octyl- and nonylphenol ethoxylates and some carboxylated derivatives in three american wastewater treatment plants

The fate of a comprehensive group of nonylphenol and octylphenol ethoxylates (APEOs) and several of their carboxylated derivatives was studied in three American wastewatertreatment plants (WWTPs), two of which included advanced treatment. Influent and effluent concentrations of the alkylphenolic compounds (APEs) in the three plants were very similar, but effluent concentrations showed a seasonal dependency: both carboxylate and ethoxylate concentrations in the effluents were higher in winter than in summer. Sorption to particulate matter was higher for nonylphenolic compounds than for their octylphenolic counterparts, in agreement with their difference in Kow values. Both effluent concentrations and the removal efficiency of the APEOs were strongly correlated to water temperature, but no correlation was found with suspended solids or organic carbon removal. Although APEO removal from wastewater was high, overall removal from the WWTPs, including APEOs in waste sludge and transformation products, was relatively low and suggested that advanced treatment does not invariably result in better APEO removal. Additionally, a survey of urban sewers suggested that household products still constitute an important source of the APEOs reaching WWTPs.     

Selective enzyme-linked immunosorbent assay for triclosan. Application to wastewater treatment plant effluents

A sensitive and highly selective enzyme-linked immunosorbent assay was developed for triclosan, one of the most common bactericides in personal care products, which is also considered as an emerging contaminant, given its presence in the effluents of sewage and wastewater treatment plants. From synthesized haptens, polyclonal rabbit antibodies against triclosan were raised. The best ELISA immunoassay was based on an antibody-coated format, yielding a detection limit of 0.03 microg L(-1), an I50 of 3.85 microg L(-1), and a dynamic range from 0.22 to 42.16 microg L(-1), with little or no cross-reactivity (< 10%) to similarly structured compounds, including its metabolite methyltriclosan (CR < 6%). The assay was applied as a screening method to quantify triclosan in surface water and in wastewaters. After C18 solid-phase extraction, nanogram per liter concentrations were determined in effluents of urban wastewater treatment plants. The satisfactory recoveries achieved as well as the agreement between immunochemical and chromatographic methods (GC-MS) indicate its potential for either screening or laboratory quantification.     

Occurrence and fate of organic contaminants during onsite wastewater treatment

Onsite wastewater treatment systems serve approximately 25% of the U.S. population. However, little is known regarding the occurrence and fate of organic wastewater contaminants (OWCs), including endocrine disrupting compounds, during onsite treatment. A range of OWCs including surfactant metabolites, steroids, stimulants, metal-chelating agents, disinfectants, antimicrobial agents, and pharmaceutical compounds was quantified in wastewater from 30 onsite treatment systems in Summit and Jefferson Counties, CO. The onsite systems represent a range of residential and nonresidential sources. Eighty eight percent of the 24 target compounds were detected in one or more samples, and several compounds were detected in every wastewater sampled. The wastewater matrices were complex and showed unique differences between source types due to differences in water and consumer product use. Nonresidential sources generally had more OWCs at higher concentrations than residential sources. Additional aerobic biofilter-based treatment beyond the traditional anaerobic tank-based treatment enhanced removal for many OWCs. Removal mechanisms included volatilization, biotransformation, and sorption with efficiencies from <1% to >99% depending on treatment type and physicochemical properties of the compound. Even with high removal rates during confined unit onsite treatment, OWCs are discharged to soil dispersal units at loadings up to 20 mg/m2/d, emphasizing the importance of understanding removal mechanisms and efficiencies in onsite treatment systems that discharge to the soil and water environments.     

纳米TiO2胶体絮凝-光催化氧化-砂滤深度处理造纸废水研究

研究了纳米TiO₂胶体絮凝-光催化氧化-砂滤深度处理造纸废水的效果。分析了絮凝剂的选择和用量、光催化剂用量、光催化时间和外加氧化剂等对废水COD_Cr去除效果的影响;研究证实了样品中残留微量纳米TiO₂胶体对COD_Cr测定的影响,并利用砂滤除去。实验结果表明,以用量为0.01%(相对于废水质量,下同)的纳米TiO₂胶体为絮凝剂对经序列间歇式活性污泥法（SBR）处理后的造纸废水进行处理,在光催化剂用量（质量分数）0.05%,曝气并紫外光照射2 h时,沉降后的上层液体经过砂滤,废水COD_Cr从210 mg/L降到43.0 mg/L。     

Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection

The presence on the market of illegal products for slimming purposes or the treatment of overweight is a public health issue. These products may contain illicit chemicals in order to improve their effectiveness. Some of these weight-loss compounds are responsible for adverse events, including fatal outcomes. A general strategy for the analysis of any suspect formulation begins with a large screening for the general search of a wide range of compounds. A methodology for the qualitative and quantitative determination of 34 compounds in slimming preparations (such as dietary supplements or medicinal products) was used for the control of slimming formulations from the market, including over the Internet. The fast liquid chromatography system (ultra-high-pressure liquid chromatography) used a gradient of solvent (phosphate buffer and acetonitrile), a C18 endcapped column and a diode array detector. This system allows dual identification based on retention time and UV spectra. The analytical method is simple, fast and selective since 34 weight-loss compounds can be detected in a 15-min run time. Thus, 32 commercial slimming formulations were analysed using this method, allowing the detection and quantification of hazardous active substances: caffeine, clenbuterol, nicotinamide, phenolphthalein, rimonabant, sibutramine, didesmethylsibutramine, synephrine and yohimbine.     

Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection

The presence on the market of illegal products for slimming purposes or the treatment of overweight is a public health issue. These products may contain illicit chemicals in order to improve their effectiveness. Some of these weight-loss compounds are responsible for adverse events, including fatal outcomes. A general strategy for the analysis of any suspect formulation begins with a large screening for the general search of a wide range of compounds. A methodology for the qualitative and quantitative determination of 34 compounds in slimming preparations (such as dietary supplements or medicinal products) was used for the control of slimming formulations from the market, including over the Internet. The fast liquid chromatography system (ultra-high-pressure liquid chromatography) used a gradient of solvent (phosphate buffer and acetonitrile), a C18 endcapped column and a diode array detector. This system allows dual identification based on retention time and UV spectra. The analytical method is simple, fast and selective since 34 weight-loss compounds can be detected in a 15-min run time. Thus, 32 commercial slimming formulations were analysed using this method, allowing the detection and quantification of hazardous active substances: caffeine, clenbuterol, nicotinamide, phenolphthalein, rimonabant, sibutramine, didesmethylsibutramine, synephrine and yohimbine.     

印染废水中苯胺类化合物处理的研究进展

新版GB 4287—2012《纺织染整工业水污染物排放标准》要求印染废水不得检出苯胺类化合物,这对现有的印染废水处理技术和工艺提出了新的挑战。文中综述了苯胺类化合物的结构和性质,印染废水中苯胺类物质的来源及其测定方法,苯胺类污染物的去除方法等,并在此基础上对印染废水中苯胺类化合物的处理技术进行了展望。     

Evidence for dechlorination of polychlorinated biphenyls and polychlorinated dibenzo-p-dioxins and -furans in wastewater collection systems in the New York metropolitan area

Polychlorinated biphenyls (PCBs) and polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) are persistent organic pollutants targeted by the Stockholm Convention. Both contain aromatic chlorines and are subject to microbial dechlorination. Dechlorination of PCBs in sewers in the Delaware River basin was recently reported. In this work, two data sets on concentrations of PCBs and PCBs+PCDD/Fs in wastewater treatment plant influents and effluents were analyzed to look for evidence that these compounds undergo dechlorination in the sewers of the New York/New Jersey Harbor area. The two data sets come from the Contamination Assessment and Reduction Project (CARP) and were analyzed via Positive Matrix Factorization (PMF). Analysis of the data set containing only PCB concentrations suggests that PCBs are dechlorinated in the sewers of the NY/NJ Harbor via the same pathways observed in the sewers of the Delaware River basin and that advanced dechlorination of PCB mixtures is more likely to occur in combined sewers vs separate sanitary sewers. When the combined data set of PCBs+PCDD/Fs was analyzed, the factor containing PCB dechlorination products also contained high proportions of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD), a known product of the dechlorination of octachlorodibenzo-p-dioxin (OCDD), and other known dechlorination products of PCDD/Fs. Despite being the most abundant PCDD/F congener in all of the samples in the database, OCDD was a minor component in the dechlorination factor. This provides the first evidence that PCDD/Fs may be dechlorinated in sewers.